Paul L. Berns, See Remarks at Neumora Therapeutics, Inc. (NMRA), sold 9,819 shares at $3.51 ($34K) on 2026-02-17, disclosed to the SEC on 2026-02-19.
Open-market sale of $34k NMRA by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NMRA | SELL | 2025-02-20 | $23K | — | Filing → |
| MTSR | BUY | 2025-02-03 | $14.2M | — | Filing → |
| JAZZ | SELL | 2021-08-09 | $223K | — | Filing → |